Merck Digital Sciences Studio’s SciMar ONE is already demonstrating early value
Last year, McKesson Ventures joined a group of funders including Merck, Microsoft, the Global Health Innovation Fund, Northpond Ventures, and the New Jersey Institute of Technology to bring to life a “founder-friendly” startup accelerator for companies in the biopharma industry. That accelerator is the Merck Digital Sciences Studio. By participating in the Merck Digital Sciences Studio, which provides mentorship, coaching, training, support, community, and investment to enable the next generation of innovative technology for drug discovery and development, startup founders gain access to up to $150,000...